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What’s Known on This Subject What This Study Adds 
The causes of LCP disease are largely unknown, but this pediatric disease seems to result This study identiﬁed associations with LCP disease for maternal smoking during preg­
from interruption of the blood supply to the proximal femur and is considered a vascular nancy and low birth weight, which suggests that exposures associated with impaired 
disease. fetal development, such as maternal smoking, may restrict the vasculature of the fem­
oral head, increasing LCP disease risk. 
ABSTRACT 
OBJECTIVE. The causes of Legg-Calve´-Perthes disease are largely unknown, but this 
pediatric disease seems to result from interruption of the blood supply to the 
proximal femur and is considered a vascular disease. Because maternal smoking 
during pregnancy inﬂuences fetal development and is associated with cardiovascular 
diseases in offspring, we hypothesized that this exposure is a risk for Legg-Calve´-
Perthes disease and also investigated other markers of impaired fetal development 
and early-life exposures. 
MATERIALS AND METHODS. The Swedish Inpatient Register identiﬁed 852 individuals 
with a diagnosis of Legg-Calve´ -Perthes disease from 1983 to 2005, individually 
matched by year of birth, age, sex, and region of residence with 4432 randomly 
selected control subjects. Linkage with the Swedish Medical Birth Register pro-
vided information on prenatal factors, including maternal smoking. Conditional 
logistic regression examined associations of maternal smoking during pregnancy 
and the other measures with the risk of Legg-Calve´ -Perthes disease in offspring, 
adjusted for socioeconomic index and other potential confounding factors. 
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almost 100%. Very low birth weight and cesarean section were independently American Academy of Pediatrics 
associated with �240% and 36% increases in the risk of Legg-Calve´-Perthes disease, 
respectively. 
CONCLUSION. Maternal smoking during pregnancy and other factors indicated by impaired fetal development may be 
associated with an increased risk of Legg-Calve´-Perthes disease. Pediatrics 2008;122:e459–e464 
LEGG-CALVE´ -PERTHES (LCP) DISEASE is deﬁned as ischemic necrosis of the femoral head among children <15 years old.1–3 It occurs mostly between ages 4 and 8 years with a male/female ratio of 3 to 5:1.4–6 The prevalence range 
has been estimated at 0.2 to 29.0 per 100 000 in children <14 years old,7,8 and among Swedish children a prevalence 
of 8.5 per 100 000 has been identiﬁed.9 Although the precise cause of LCP is unknown, this disease is considered a 
vascular condition involving interruption of the blood supply to the proximal femur.1–3,10–12 The medial femoral 
circumﬂex artery is the principal source of blood supply to the femoral head. Several possible risk factors for the 
disease have been suggested, including impaired and disproportionate growth,13 low birth weight,14,15 delayed skeletal 
maturity,16 short stature,13,17 systemic hormonal changes,18–22 and low socioeconomic index.23–27 Several of these 
factors are consistent with the hypothesis that some form of developmental impairment is implicated in the etiology 
of LCP disease, possibly because of restricted development of the vasculature to the proximal femur. Associations 
with low birth weight and impaired fetal growth14,15 suggest that prenatal and other early-life factors may be 
important in determining disease risk. 
A small number of earlier studies reported associations between exposure to environmental tobacco smoke and 
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LCP disease.28–30 Although it is particularly difﬁcult to 
draw ﬁrm conclusions about causation from these stud­
ies, they reported a positive association; the ﬁndings 
suggest that parental smoking may represent a risk fac­
tor. We hypothesized that maternal smoking during 
pregnancy may be a speciﬁc risk, because this has been 
associated with cardiovascular disease risk and intima­
media thickness in offspring during early life,31 which 
indicates early damage to blood vessels. Smoking during 
pregnancy has been linked with low birth weight and 
impaired fetal growth,32,33 providing evidence that it may 
be relevant to LCP disease risk. Thus, because both LCP 
disease and smoking during pregnancy are associated 
with impaired fetal development and vascular abnor­
malities, it is feasible that smoking during pregnancy is 
associated with a raised risk of LCP disease among off­
spring. 
This case-control study using material from Swedish 
general population-based registers was designed speciﬁ­
cally to examine the hypothesis that maternal smoking 
during pregnancy is associated with an increased risk of 
LCP disease among offspring; we know of no other stud­
ies that have investigated this hypothesis to date. We 
also evaluated the risk associated with birth weight, 
body size at birth, gestational age, presentation of the 
infant, delivery mode, Apgar score, maternal age, birth 
order, and history of earlier pregnancies. These measures 
were selected as relevant to fetal development and early 
trauma. 
MATERIALS AND METHODS 
We identiﬁed all of the patients in the Swedish Inpatient 
Register with a diagnosis of LCP disease (International 
Classiﬁcation of Diseases [ICD]-8 codes 722.10, 722.11, and 
722.19; ICD-9 code 732B; and ICD-10 codes M91.1, 
M91.2, and M91.3) between 1982 and 2005. The Swed­
ish Inpatient Register includes data on individual hospi­
tal admissions collected by the Swedish National Board 
of Health and Welfare since 1964. Each record contains 
the national registration number, a unique personal 
identiﬁer assigned to every Swedish resident from birth 
or immigration, as well as medical data, including dis­
charge diagnoses. Subjects with LCP disease were individ­
ually matched with -5 individuals without the disease by 
Statistics Sweden, the government agency responsible for 
population statistics. The matching criteria were year of 
birth, age, sex, and region of residence at the time of 
diagnosis in the case subjects. 
The Swedish Medical Birth Register includes informa­
tion collected prospectively during pregnancy, delivery, 
and the neonatal period on virtually all births in Sweden 
since 1973. From 1982, women were asked about smok­
ing during their ﬁrst prenatal visit, which occurs before 
the 15th week of gestation in >95% of pregnancies in 
Sweden.34 In this register, gestational age is based largely 
on early second-trimester ultrasound examination, 
when available, or is estimated from the date of the last 
menstrual period. The national registration number en­
ables linkage between mothers and their offspring. 
Through linkage with the Total Population Register, we 
identiﬁed participants’ date of birth, sex, region of resi­
dence at diagnosis, dates of death, and emigration. Cen­
sus data provided the socioeconomic index of parents on 
the basis of occupation (manual workers, nonmanual 
workers, self-employed, farmers, and others). In total we 
identiﬁed 924 case subjects and 4550 matched control 
subjects born after 1982. We excluded 14 case subjects 
because of lack of matched control subjects, as well as 72 
case subjects and 118 control subjects because we could 
not link them with their mothers in the Swedish Medical 
Birth Register. The analysis was, thus, based on 852 case 
subjects and 4432 matched control subjects. The distri­
bution of missing data for the putative risk factors (in­
cluding 84 case subjects and 397 control subjects for 
smoking during pregnancy, 3 case subjects and 16 con­
trol subjects for birth weight, and 10 case subjects and 54 
control subjects for birth length) did not vary notably 
between case subjects and control subjects, indicating 
that differential selection bias is unlikely to represent a 
problem. The study was approved by the ethics research 
committee at the Karolinska Institutet. 
Statistical Analysis 
We used conditional logistic regression to evaluate asso­
ciations between maternal smoking during pregnancy 
and risk of LCP disease among offspring. Odds ratios 
(ORs) and 95% conﬁdence intervals (CIs) were used to 
approximate relative risks. Associations between mater­
nal smoking and the risk of LCP disease among offspring 
were evaluated using smoking as both a dichotomous 
measure (smoker or nonsmoker) and an ordinal factor 
categorized as nonsmoker, moderate smoker (1–9 ciga­
rettes per day), and heavy smoker (:10 cigarettes per 
day). First we used univariate conditional logistic regres­
sion models to evaluate the OR for each potential risk or 
confounding factor. The variables were maternal smok­
ing during pregnancy, maternal age categorized into ter­
tiles (<25, 25–29, or :30 years), malpresentation of the 
infant at the time of delivery, breech birth, birth weight 
(<1500, 1500–2499, 2500 –4499, or :4500 g), birth 
length categorized into tertiles (<49, 49–51, or >51 
cm), head circumference categorized into tertiles (<34, 
34–36, or >36 cm), small for gestational age standard­
ized by gestational week, gestational age (<32, 32–36, 
37–42, or >42 weeks), any infection in the infant reg­
istered in the birth records, any trauma during delivery, 
any complication during delivery, cesarean section, Ap­
gar score at the ﬁrst minute after delivery (<4,  4–6,  or  
>6), birth order (ﬁrst born, second, third, or fourth or 
later), previous stillbirth, and previous spontaneous 
abortions. Then we used multivariate conditional logistic 
regression models to estimate adjusted ORs. In the uni­
variate analysis we excluded observations with missing 
values, so the total number of subjects varied by vari­
able. 
Another model included the a priori putative risk 
factors, maternal smoking and fetal growth restriction, 
as well as variables that had statistically signiﬁcant uni­
variate associations, gestational age and socioeconomic 
index. In the multivariate analysis, subjects with missing 
values for any of the included variables were excluded. 
Only 1 of the measures of fetal growth was included, to 
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TABLE 1 Characteristics of Case and Control Subjects 
Case Control 
Subjects Subjects 
Total No. 852 4432 
Male, % 79.7 79.4 
Age at diagnosis, n 
<3 y 16 90 
3–5 y 187 978 
6–8 y 401 2066 
9–12 y 180 934
 
>12 y 68 364 
Gestational duration, n 
<32 wk 9 41 
32–36 wk 65 240
 
37–42 wk 773 4114 
>42 wk 5 37 
Maternal smoking in the pregnancy, n 
None 501 3066 
<10 cigarettes per d 149 625
 
:10 cigarettes per d 118 344 
Missing 85 397 
Smoking during pregnancy 
No 501 3066 Reference 
<10 cigarettes per d 149 625 1.44 (1.18–1.77) 
:10 cigarette per d 118 344 2.07 (1.64–2.61) 
Mother’s age
 
<25 y 202 982 1.02 (0.85 –1.24) 
25–29 y 326 1608 Reference 
:30 y 324 1842 0.87 (0.74–1.03) 
Birth weight
 
<1500 g 11 22 2.36 (1.29–4.33) 
1500–2499 g 37 146 1.35 (1.04–1.75) 
2500–4499 g 773 4079 Reference 
:4500 g 28 169 0.97 (0.72–1.30) 
Birth length, tertile
 
<49 cm 321 1278 1.24 (1.01–1.52) 
49–51 cm 167 822 Reference 
>51 cm	 354 2278 0.76 (0.62–0.93) 
Head circumference, tertile 
<34 cm 185 775 1.28 (1.06–1.56) 
34–36 cm 391 2044 Reference 
>36 cm 251 1473 0.90 (0.76–1.07) 
Small for gestational age 
No	 791 4183 Reference
Yes
<32 wk	 3 4 4.44 (1.03–19.09) 
32–36 wk	 6 19 1.77 (0.70–3.27) 
37–42 wk 24 91 1.38 (1.09–1.91) 
:43 wk 1 1 5.00 (0.31–79.95) 
Gestational age 
<32 wk 9 41 1.13 (0.56–2.31) 
32–36 wk 65 240 1.41 (1.07–1.87) 
37–42 wk 773 4114 Reference 
>42 wk 5 37 0.71 (0.28–1.79) 
cesarean section 
No	 673 3698 Reference
Yes	 179 734 1.32 (1.10–1.58) 
Apgar score 1 
<4 11 55 1.07 (0.56–2.03) 
4–6 30 145 1.07 (0.72–1.58) 
>6 800 4187 Reference 
Malpresentation 
No 779 4216 Reference 
Yes 53 216 1.28 (0.94–1.74) 
Breech birth 
No	 841 4350 Reference
Yes	 11 82 0.73 (0.39–1.37) 
Any complication during delivery 
No 684 3685 Reference 
Yes 168 747 1.20 (1.00–1.45) 
Trauma during delivery, general 
No 823 4278 Reference 
Yes 29 154 1.01 (0.67–1.50) 
Trauma during delivery, skeletal 
No 837 4337 Reference
Yes	 15 95 0.84 (0.49–1.46) 
Infection in child 
No	 833 4361 Reference
Yes	 19 71 1.38 (0.83–2.29) 
Child order 
First 323 1742 Reference 
Second 321 1645 1.06 (0.89–1.25) 
TABLE 2 Risk of LCP Disease Associated With Some Early-Life 
Factors 
Parameter Case Control OR (95% CI) 
Subjects, n Subjects, n 
avoid colinearity. Although it is possible that low birth 
weight could be intermediate in a causal pathway between 
maternal smoking and LCP disease, we included both of 
these measures in the same model to estimate their inde­
pendence from each other. Another model excluded birth 
weight to assess whether its inclusion in the model masked 
an association with maternal smoking. 
A test for trend of relative risks for smoking during 
pregnancy was performed by calculating the difference 
in deviance derived from the models, including and 
excluding the explanatory variable treated semicontinu-
ously, and interpreting the difference as a x2 statistic 
with 1 degree of freedom. We also examined whether 
there was evidence of differences in association by per-
forming analyses stratiﬁed by gender and age of diagno-
sis categorized into tertiles (<6, 6–8, and >8 years). All 
of the statistical analyses were performed by using SAS 
9.1 (SAS Institute, Inc, Cary, NC).	 
RESULTS 
Table 1 shows the characteristics of the case and control 
subjects. Some 79% of the case subjects were male. In 
the univariate model, smoking during pregnancy was a 
risk factor associated with a 67% increase in the risk of 
LCP disease (OR: 1.67 [95% CI: 1.41–1.97]), and there 
was a dose-dependent trend (Table 2). Low birth weight, 
being in the lowest tertile of height or head circumfer-
ence, being small for gestational age, preterm birth, any 
complication during delivery, and cesarean section were 
associated with a raised risk of LCP disease. 
Table 3 shows the crude and adjusted ORs for smok-
ing during pregnancy, birth weight, gestational age, and 
cesarean section after excluding all of the observations 
with missing values for any of these measures and so-
cioeconomic index. In multivariate conditional logistic 
regression analysis, the associations of maternal smoking 
during pregnancy, very low birth weight, and cesarean 
section with the risk of LCP disease remained statistically 
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TABLE 2 Continued 
Parameter Case Control OR (95% CI) 
Subjects, n Subjects, n 
Third 148 743 1.08 (0.87–1.33) 
Fourth or later 60 302 1.06 (0.79–1.43) 
Previous stillbirth 
No 755 3929 Reference 
Yes 9 45 0.75 (0.30–1.89) 
Previous abortion 
No 364 1978 Reference 
Yes 
1 121 549 1.18 (0.89–1.56) 
2 20 92 1.20 (0.71–2.01) 
>2 8 37 1.18 (0.54–2.59) 
signiﬁcant after adjustment for all of these measures and 
the socioeconomic index. The statistically signiﬁcant 
positive trend, indicating a dose response, for smoking 
during pregnancy (P for trend < .0001) was observed in 
the results from in the adjusted model. In the same 
model, the point estimate was 0.93 (95% CI: 0.77–1.11), 
comparing nonmanual workers with manual workers, 
after adjustment for all of the aforementioned measures. 
When we excluded maternal smoking from the mul­
tivariate conditional logistic regression model, the results 
for the other covariates (birth weight, gestational age, 
and cesarean section) remained stable (data not shown). 
Removing birth weight from the adjusted model did not 
change the point estimates for maternal smoking and 
the other covariates (data not shown). 
Stratiﬁed analyses showed that the association be­
tween LCP disease and maternal smoking during preg­
nancy was consistent, with a dose-dependent trend, for 
both male subjects (OR for moderate smoker: 1.42 [95% 
CI: 1.12–1.81]; OR for heavy smoker: 1.92 [95% CI: 
1.45–2.53]) and female subjects (OR for moderate smoker: 
1.17 [95% CI: 0.73–1.86]; OR for heavy smoker: 2.47 
[95% CI: 1.47–4.15]). The point estimates for birth 
weight, gestational age, and cesarean section were stable 
in the stratiﬁed analyses, although they were based on 
small numbers, especially for female subjects. No con­
spicuous variation in the ORs was observed in analyses 
stratiﬁed by age of onset (data not shown). 
DISCUSSION 
This study found a statistically signiﬁcant dose-depen­
dant association between maternal smoking during 
pregnancy and an increased risk of LCP disease among 
offspring. We also found that low birth weight adjusted 
for gestational age was associated with LCP disease and 
that delivery by cesarean section represented a modestly 
increased risk. 
Although this study cannot identify causation, it is 
plausible that maternal smoking during pregnancy could 
inﬂuence the risk of LCP disease, because it is known 
that smoking has direct effects on the fetus. A direct 
effect has been shown for other diseases and adverse 
pregnancy outcomes, such as low birth weight.32,33 It has 
been suggested that impaired placental function,35 re­
duced uteroplacental blood ﬂow,36 or inﬂuences on fetal 
oxygen supply could be responsible for the harmful 
effects on the fetus of maternal smoking during preg­
nancy. The apparently large effect on femoral devel­
opment associated with maternal smoking during 
pregnancy32 also suggests that this exposure may be 
relevant to LCP disease risk. The mechanism underlying 
the putative associations with LCP for maternal smoking 
and other risk factors could be through impaired in utero 
growth and development, particularly where this results 
in inadequate development of the femur32 or associated 
blood vessels.31 It has been shown that maternal smok­
ing in utero exposes the fetus to oxidative stress,37 which 
has been implicated in the pathogenesis of atherosclero­
sis. Additional evidence that impaired fetal development 
or associated exposures are implicated in LCP disease 
etiology comes from the consistent associations with 
TABLE 3 Risk of LCP Disease Associated With Some Early-Life Factors: Multivariate Model 
Parameter Case Control Unadjusted, OR (95% CI) Adjusted, OR (95% CI)a 
Subjects, n Subjects, n 
Smoking during pregnancy 
No 483 2880 Reference Reference 
1–9 cigarettes per d 141 594 1.38 (1.12–1.70) 1.36 (1.10–1.68) 
:10 cigarettes per d 114 323 2.08 (1.64–2.64) 2.02 (1.59–2.58) 
Birth weight 
<1500 g 9 18 2.34 (1.05–5.19) 3.46 (1.11–10.84) 
1500–2499 g 33 121 1.41 (0.95–2.08) 1.14 (0.72–1.81) 
2500–4499 g 671 3513 Reference Reference 
:4500 g 25 145 0.94 (0.61–1.46) 0.99 (0.64–1.54) 
Gestational age 
<32 wk 5 27 0.91 (0.35–2.35) 0.29 (0.08–1.07) 
32–36 wk 58 202 1.46 (1.08–1.98) 1.21 (0.84–1.73) 
37–42 wk 672 3536 Reference Reference 
>42 wk 3 32 0.51 (0.16–1.66) 0.47 (0.14–1.53) 
Cesarean section 
No 582 3196 Reference Reference 
Yes 156 601 1.40 (1.14–1.70) 1.36 (1.11–1.67) 
a Data were adjusted for all of the variables in the table and socioeconomic index. 
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birth weight, recumbent length, head circumference, 
and being small for gestational age. The association of 
these measures with LCP risk is of lower magnitude than 
for maternal smoking, and the association with maternal 
smoking is independent of the measures of growth. A 
range of factors inﬂuence birth weight, but different 
exposures may result in different aspects of developmen­
tal impairment, suggesting a more important role in the 
etiology of LCP disease for some exposures that inﬂu­
ence early development. It is also possible that maternal 
smoking is a proxy indicator of other factors, which 
might be causally associated with LCP, for example, 
other hazardous health behaviors, nutrition, and fetal 
micronutrient supply. In this study it was not possible to 
obtain information on smoking before pregnancy or a 
wealth of other potential confounding factors associated 
with maternal smoking, so the nature of causality in this 
association must remain speculative. The small effect of 
adjustment for available potential confounding factors 
and the dose-dependent association does no rule out a 
more direct association between maternal smoking dur­
ing pregnancy and LCP disease. 
We observed that the association between cesarean 
section and LCP disease remains statistically signiﬁcant 
after adjustment for other risk factors. The reason for 
cesarean section is not recorded in the register data, so it 
is not possible to explore fully the reasons underlying 
this association. It is conceivable that some conditions 
associated with impaired fetal development, which also 
increased LCP disease risk, resulted in delivery by cesar­
ean section. Measures such as breech birth and trauma 
were not associated with LCP disease risk, suggesting 
that inﬂuences on earlier development, rather than peri­
natal trauma, are involved in the etiology of the disease. 
Although we identiﬁed associations with smoking dur­
ing pregnancy, earlier maternal smoking could theoret­
ically inﬂuence fetal development through epigenetic 
mechanisms, altering gene expression through the pla­
centa or the cytoplasm of the egg. 
To our knowledge, this is the ﬁrst study to date that 
has investigated maternal cigarette smoking speciﬁcally 
during pregnancy and the risk of LCP disease. Three 
previous studies showed an association between passive 
smoking and LCP disease.28–30 However, methodologic 
limitations, such as small numbers of case subjects, pre­
vent any ﬁrm conclusions being drawn from these stud­
ies. If there was an association between maternal smok­
ing during pregnancy and the risk of LCP disease, it 
would be unsurprising to ﬁnd an association with pas­
sive smoking after birth, because women rarely give up 
smoking completely.38,39 Men with a spouse who smoke 
are also more likely to smoke,40 so associations of LCP 
disease with paternal smoking may be confounded by 
maternal smoking, including during pregnancy. Addi­
tional evidence that exposure to environmental tobacco 
smoke after birth is not a substantial risk comes from our 
stratiﬁed analysis of age at diagnosis: there was no pat­
tern for the risk of LCP disease by age of onset. Because 
onset age also indicates duration of previous exposure, 
this suggests that environmental tobacco smoke is not 
associated with disease risk. Although passive smoking 
after birth is a less plausible risk for LCP disease than 
smoking during pregnancy, we cannot rule out the pos­
sible additive effect of this exposure after birth. It has 
been shown that exposure to environmental tobacco 
smoke may be associated with arterial abnormalities in 
children,41 and it is conceivable that children who were 
exposed to smoking in utero could also be more suscep­
tible to endothelial dysfunction caused by passive smok­
ing after birth. This may also inﬂuence susceptibility to 
infections, but because we found no notable association 
of infections with LCP disease, we do not believe that 
this explains the association with maternal smoking dur­
ing pregnancy. One of the strengths of this study is its 
large sample size. The general population-based nature 
of the sample is another strength, indicating that the 
ﬁndings are not limited to a subset of the population. 
More than 95% of pregnancies would have been re­
corded in the registers used here.34 The unique national 
registration number permits virtually complete linkage 
of individual information in the inpatient register with 
data on mothers receiving prenatal care and their in­
fants. Information on cigarette smoking during preg­
nancy was recorded prospectively, thus limiting the pos­
sibility of recall or reporting bias and selection bias. One 
of the limitations of the present study is that the details 
of cigarette smoking were based on self-reported infor­
mation in the ﬁrst visit after pregnancy, and it is possible 
that women underreported smoking.42 However, the 
measurement of cigarette smoking in the Swedish Med­
ical Birth Register is reported to be reasonably accu­
rate.43,44 As pregnant women receive information about 
the harmful effects of smoking, it is also probable that 
some smokers gave up after the ﬁrst visit. This may have 
resulted in an underestimation of the magnitude of the 
association between smoking and LCP disease. Like most 
other register-based studies, we lack information on 
some potentially important measures, such as maternal 
nutrition, other lifestyle factors, and smoking behavior 
before and after pregnancy. However, we adjusted the 
model for socioeconomic index on the basis of occupa­
tion, which is associated with smoking and many other 
important lifestyle factors. 
CONCLUSIONS 
This study identiﬁed associations with LCP disease for 
maternal smoking during pregnancy and low birth 
weight. This suggests that exposures associated with im­
paired fetal development, such as maternal smoking, 
may restrict the vasculature of the femoral head, in­
creasing LCP disease risk. 
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